引用本文: | 闫小龙, 夏津. 厄洛替尼对比长春瑞滨联合顺铂辅助治疗ⅢA期EGFR突变阳性非小细胞肺癌患者的疗效[J]. 循证医学, 2019, 19(1): 44-46. DOI: 10.12019/j.issn.1671-5144.2019.01.012 |
Citation: | YAN Xiao-long, XIA Jin. Efficacy of Erlotinib Versus Vinorelbine Plus Cisplatin as Adjuvant Therapy for StageⅢA EGFR Mutation-Positive Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(1): 44-46. DOI: 10.12019/j.issn.1671-5144.2019.01.012 |